DXCM vs WRBY · P/E 63, rev $2.50B vs rev $478.0M
DexCom Inc (DXCM) versus Warby Parker Inc (WRBY) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Warby Parker Inc (WRBY) is a medical instruments & supplies company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported WRBY revenue for 2026-06-30 was $478.0M. Net income was $7.8M. Revenue was up 97.1% from 2026-03-31 to 2026-06-30. WRBY currently screens at market cap $2.70B.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. WRBY currently screens at market cap $2.70B.
Not investment advice. Open the DXCM and WRBY stock pages for the full models.
Not investment advice.